Dr. Lal Path Labs Ltd.

NSE: LALPATHLAB · Healthcare

₹1,942.10

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bearish 58% confidence

Price trapped below 200-day EMA in a 12-month downtrend; recent 3-month bounce lacks fundamental support ahead of November 4 results.

Strongest bull point

Q1 FY27 earnings showed strong +24.4% YoY growth, and confirmed SN Genelab acquisition (₹199.5 crore) signals inorganic growth strategy in consolidating diagnostics sector.

Strongest bear point

Stock down 40% in 12 months (31.5% worse than NIFTY), price still 1.64% below 200-day EMA confirming downtrend intact, and 49% recovery from lows is classic bear-trap pattern within larger decline.

Technical Forecast · next 10 trading days

Expected

₹1,701.08 -12.4%

Range

₹1,694.84 – ₹1,702.35

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on LALPATHLAB, misses included

Bearish 28 Sep 2026 → now Scores 28 Oct 2026

₹1,942.10 → ₹1,942.10 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare